Get the Stockscreener App
11.50
3.36%
-0.40
Pre-market:
11.33
-0.17
-1.48%
Lifestance Health Group Inc stock is traded at $11.50, with a volume of 5.81M.
It is down -3.36% in the last 24 hours and up +7.43% over the past month.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
See More
Previous Close:
$11.90
Open:
$11.79
24h Volume:
5.81M
Relative Volume:
1.34
Market Cap:
$4.39B
Revenue:
$1.49B
Net Income/Loss:
$23.20M
P/E Ratio:
194.26
EPS:
0.0592
Net Cash Flow:
$142.63M
1W Performance:
+12.09%
1M Performance:
+7.43%
6M Performance:
+65.95%
1Y Performance:
+151.64%
1-Day Range:
$11.36
$11.93
1-Week Range:
$10.08
$12.43
52-Week Range:
$4.52
$12.43
Lifestance Health Group Inc Stock (LFST) Company Profile
Name
Lifestance Health Group Inc
Sector
Industry
Phone
602-767-2100
Address
4800 N. SCOTTSDALE ROAD, SCOTTSDALE
Compare LFST vs HCA, THC, FMS, EHC, DVA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFST
Lifestance Health Group Inc
|
11.50 | 4.15B | 1.49B | 23.20M | 142.63M | 0.0592 |
HCA
Hca Healthcare Inc
|
411.44 | 86.43B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
259.45 | 20.96B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
23.87 | 13.36B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
125.35 | 11.30B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
178.34 | 15.17B | 13.84B | 1.10B | 1.49B | 10.42 |
Lifestance Health Group Inc Stock (LFST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Jul-25-25 | Initiated | BTIG Research | Buy |
| May-27-25 | Upgrade | UBS | Neutral → Buy |
| Apr-08-25 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-03-25 | Initiated | Canaccord Genuity | Buy |
| Dec-16-24 | Upgrade | Goldman | Neutral → Buy |
| Jan-03-24 | Initiated | Barclays | Underweight |
| May-15-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jan-06-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-07-22 | Resumed | Jefferies | Buy |
| Mar-17-22 | Downgrade | UBS | Buy → Neutral |
| Nov-09-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Aug-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-06-21 | Initiated | Goldman | Neutral |
| Jul-06-21 | Initiated | JP Morgan | Overweight |
| Jul-06-21 | Initiated | Jefferies | Buy |
| Jul-06-21 | Initiated | Morgan Stanley | Overweight |
| Jul-06-21 | Initiated | William Blair | Outperform |
View All
Lifestance Health Group Inc Stock (LFST) Latest News
LifeStance Health Group Inc (LFST) Shares Fall 3.4% -- GF Value Says Still Overvalued - GuruFocus
LifeStance Health (LFST) holder files to sell 500,000 common shares via Fidelity - Stock Titan
Summit Partners group (LFST) discloses 6.10% LifeStance Health ownership in 13G/A - Stock Titan
LifeStance Health (LFST) Upgraded to Buy: Here's Why - finance.yahoo.com
LifeStance Health Group, Inc. (LFST) Soars to 52-Week High, Time to Cash Out? - finance.yahoo.com
LifeStance Survey Finds Women Want Mental Healthcare Built Into Perimenopause and Menopause Care - finance.yahoo.com
Citadel Securities files to sell 13.6M LFST (LFST) shares under Rule 144 - Stock Titan
LifeStance CMO Sees Interventional Psychiatry Shifting From Last Resort to Table Stakes - Behavioral Health Business
LifeStance Health Group (LFST) holder to resell 1.7M shares under Rule 144 - Stock Titan
LifeStance Health (LFST) Form 144 shows planned sale of 1.09M shares - Stock Titan
LifeStance Health Group (LFST) holder files to sell 1,626 shares - Stock Titan
LifeStance Health Group (LFST) investor plans NASDAQ sale of 12,165 shares - Stock Titan
LifeStance Health Group (LFST) holder cites pre-IPO shares in planned resale - Stock Titan
Shareholder in LFST (LFST) files Form 144 to sell 47,912 shares - Stock Titan
LifeStance Health Group, Inc. SEC Filing (Aug 10, 2026) - Stock Titan
LifeStance Health gains as Hedgeye adds as new long idea - Seeking Alpha
LifeStance Health Group (NASDAQ:LFST) Reaches New 1-Year High After Analyst Upgrade - MarketBeat
Lifestance Health Group Inc stock hits 52-week high at 11.77 USD - Investing.com Australia
LFST Q2 Deep Dive: Margin Expansion and Specialty Services Propel Growth Outlook - Yahoo Finance UK
Surgery Partners (SGRY) Q2 Earnings: What To Expect - TradingView
LifeStance Health Group (NASDAQ:LFST) Releases Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
LifeStance Health Group, Inc.'s Equity Buyback announced on February 25, 2026, has expired. - marketscreener.com
BTIG Research Increases LifeStance Health Group (NASDAQ:LFST) Price Target to $16.00 - MarketBeat
LifeStance Health Group, Inc. (LFST) Stock forecasts - Yahoo Finance UK
Morgan Stanley Adjusts PT on Lifestance Health Group to $13 From $10, Maintains Overweight Rating - finance.yahoo.com
Lifestance Health Group Inc (LFST) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
LifeStance Health Group Inc (LFST) Stock Up 3.1% but GF Value Sa - GuruFocus
LifeStance Health Group, Inc. Stock 12‑Month Price Target Raised to $12.6, Implies 22% Upside - TradingView
LifeStance Health Group Inc (LFST) (Q2 2026) Earnings Call Highlights: Revenue Surges 26% and ... - finance.yahoo.com
Earnings call transcript: LifeStance tops Q2 2026 estimates and raises outlook - Investing.com
LifeStance Health : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q) - marketscreener.com
LifeStance Health Group Q2 Earnings Call Highlights - MarketBeat
LifeStance Health Group, Inc. Q2 2026 Earnings Call Summary - finance.yahoo.com
LifeStance Health Doubles Earnings as It Prioritizes Tuck-In M&A - Behavioral Health Business
LifeStance Health Group, Inc. Q2 2026: Revenue $435.4M, EPS $0.06— 10-Q Summary - TradingView
LifeStance Health (NASDAQ: LFST) grows Q2 2026 revenue 26% - Stock Titan
Tranche Update on LifeStance Health Group, Inc.'s Equity Buyback Plan announced on February 25, 2026. - marketscreener.com
LifeStance Health Group, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:LFST) 2026-08-06 - Seeking Alpha
LifeStance Health surges on strong Q2 beat and raised outlook By Investing.com - Investing.com UK
LifeStance Q2 2026 slides: profitability surges as margins expand - Investing.com
LifeStance Health Group, Inc. announces an Equity Buyback for $100 million worth of its shares. - marketscreener.com
LifeStance Health Group, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
LifeStance Health Group, Inc. Raises Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
LifeStance Health surges on strong Q2 beat and raised outlook - Investing.com
LifeStance Health Group (LFST) Tops Q2 Earnings and Revenue Estimates - finance.yahoo.com
Lifestance Health Swings to Q2 Profit as Revenue Rises; Raises 2026 Revenue Guidance - marketscreener.com
LifeStance Q2 2026 Earnings: Revenue Rises 26% as Profitability Expands - TradingKey
LifeStance Health Group Reports 26% Q2 Revenue Growth, Turns Profitable and Raises Full-Year 2026 Outlook - Quiver Quantitative
LifeStance Health: Q2 Earnings Snapshot - AOL.com
LifeStance Health Group (NASDAQ:LFST) Reports Strong Q2 CY2026, Guides for Strong Full-Year Sales - finance.yahoo.com
Earnings Flash (LFST) LifeStance Health Posts Q2 EPS $0.06, vs. FactSet Est of $0.04 - marketscreener.com
Lifestance Health Group Inc Stock (LFST) Financials Data
Revenue
Net Income
Cash Flow
EPS
7.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):